IRESSA - Gefitinib
Navigation: NDC > Supplier starting with: A > ASTRAZENECA PHARMACEUTICALS LP| Field | Value |
|---|---|
| NDC Code: | 0310-0482 |
| Proprietary Name: | IRESSA |
| Suffix: | |
| Non-Proprietary Name: | Gefitinib |
| Dosage Form: | TABLET, COATED |
| Method: | ORAL |
| Original Marketing Date: | 13-05-2003 |
| Category Name: | NDA |
| Application Number: | NDA021399 |
| Labeler: | ASTRAZENECA PHARMACEUTICALS LP |
| Substance Name: | GEFITINIB |
| Active Numerator Strength: | 250 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| DEA Schedule: |